LH and FSH relaese by the pituitary, de inhibitive effect of estradiol in male to female transsexuals

LH and FSH relaese by the pituitary, de inhibitive effect of estradiol in male to female transsexuals - effect of estradiol on gonadotropin release in men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30398

Enrollment

Registered

2007-03-05

Start date

2007-02-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypogonadism testosterone defciency

Interventions

estradiol is administered with a patch in varying doses (100 microgram per 24 uur, 50 microgram per 24 uur, 25 microgram per 24 uur en no oestradiol)

every dose for 7 days

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: male-to-female transsexual, after gonadectomy, age between 18-40 years (young group) or >60 years (old group)

Exclusion criteria

Exclusion criteria: use of other medication apart from estradiol, hyperprolactinemia, SHBG level >60nmol/l

Design outcomes

Primary

Measure	Time frame
blood tests for estradiol, LH and FSH	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)